SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-23-000070
Filing Date
2023-06-01
Accepted
2023-06-01 17:21:40
Documents
15
Period of Report
2023-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20230601.htm   iXBRL 8-K 44007
2 EX-10.1 ex101-slongoriasragmt.htm EX-10.1 40319
3 EX-10.2 ex102-amendedemploymentagr.htm EX-10.2 78213
4 EX-10.3 ex103-exicureretentionagre.htm EX-10.3 13895
  Complete submission text file 0001698530-23-000070.txt   349114

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20230601.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20230601_lab.xml EX-101.LAB 24831
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20230601_pre.xml EX-101.PRE 13045
9 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20230601_htm.xml XML 11364
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 23985710
SIC: 2834 Pharmaceutical Preparations